newdrugapprovals.org
FDA approves Keytruda for advanced melanoma, First PD-1 blocking drug to receive agency approval
September 4, 2014FDA ReleaseThe U.S. Food and Drug Administration today granted accelerated approval to Keytruda (pembrolizumab) for treatment of patients with advanced or unresectable melanoma who…